Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS Patients

Completed · Not applicable

Conditions studied: Irritable Bowel Syndrome (IBS)

In brief

This is an open labeled, one-armed real-world study in IBS-patients. All participants will receive active treatment for 12 weeks. The primary objective of the study is to assess the effect of Human Milk Oligosaccharides (HMOs) on bowel function in adults with IBS. Secondary objectives are to evaluate HMOs' tolerability, effect on participant reported satisfaction with bowel habits, interference with life in general, quality of life, somatic symptoms, and anxiety and depression in all patients and subgroups of patients.

Key facts

Study ID
NCT03550742
Run by
Glycom, Inc.
People needed
317
Starts
2018-05-14
Expected to finish
2019-03-20
Last updated by the study team
2019-04-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.